| |
| | NEJM -- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children (Site not responding. Last check: 2007-10-08) |
 | | Piedra, P. A., Gaglani, M. J., Riggs, M., Herschler, G., Fewlass, C., Watts, M., Kozinetz, C., Hessel, C., Glezen, W. Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial. |
 | | Gaglani, M. J., Piedra, P. A., Herschler, G. B., Griffith, M. E., Kozinetz, C. A., Riggs, M. W., Fewlass, C., Halloran, M. E., Longini, I. Jr, Glezen, W. Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy Children. |
 | | Gonzalez, M, Pirez, M C, Ward, E, Dibarboure, H, García, A, Picolet, H (2000). |
| content.nejm.org /cgi/content/abstract/342/4/225 (1847 words) |
|